Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors

Author： Morgan Robert   Synold Timothy   Mamelak Adam   Lim Dean   Al-Kadhimi Zaid   Twardowski Przemyslaw   Leong Lucille   Chow Warren   Margolin Kim   Shibata Stephen   Somlo George   Yen Yun   Frankel Paul   Doroshow James  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.66, Iss.5, 2010-10, pp. : 927-933

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I/II clinical trial of concurrent radiochemotherapy in combination with topotecan for the treatment of brain metastases

By Gruschow K.   Klautke G.   Fietkau R.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 367-374

Elsevier

Access to resources Recommend Favorite

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

By Bolis G.   Scarfone G.   Sciatta C.   Polverino G.P.   Rosa C.   Guarnerio P.   Parazzini F.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 477-480

Elsevier

Access to resources Recommend Favorite

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

By Pipas J.   Meyer Louise   Rhodes C.   Cromwell Laurence   McDonnell Carol   Kingman Linda   Rigas James   Fadul Camilo  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 301-305

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors

By Stewart Clinton   Tagen Michael   Schwartzberg Lee   Blakely L.   Tauer Kurt   Smiley Linda  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 561-568

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Trial of a 3-Day Topotecan Q 21 Days for Recurrent Epithelial Cancers of the Ovary, Fallopian Tube, and Peritoneum

By Brown J.V.   Peters W.A.   Rettenmaier M.A.   Karlan B.Y.   Dillman R.A.   Smith M.R.   Drescher C.W.   Micha J.P.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 495-498

Elsevier

Access to resources Recommend Favorite